Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

CHO Pharma, Inc. (6586) Income Statement

CHO Pharma, Inc. Income Statement

Last quarter (Q2 2026), CHO Pharma, Inc.'s total revenue was NT$986.00K, a decrease of 8.87% from the same quarter last year. In Q2, CHO Pharma, Inc.'s net income was NT$-96.16M. See CHO Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.43MNT$ 3.58MNT$ 0.00NT$ 60.00KNT$ 3.57M
NT$ -25.54MNT$ 1.71MNT$ -28.28MNT$ 59.00KNT$ 3.36M
NT$ 300.30MNT$ 251.00MNT$ 269.00MNT$ 350.96MNT$ 213.85M
Depreciation and AmortizationNT$ 26.69MNT$ 25.90MNT$ 28.28MNT$ 39.85MNT$ 39.08M
NT$ -299.15MNT$ -185.65MNT$ -277.73MNT$ -298.24MNT$ -166.27M
NT$ -325.84MNT$ -249.29MNT$ -269.00MNT$ -350.90MNT$ -210.49M
NT$ 35.84MNT$ 37.07MNT$ -37.09MNT$ 12.51MNT$ 4.57M
NT$ -290.01MNT$ -212.23MNT$ -306.09MNT$ -338.39MNT$ -205.93M
NT$ -290.01MNT$ -212.23MNT$ -306.09MNT$ -338.39MNT$ -205.93M
Per Share Metrics
Basic EPSNT$ -1.36NT$ -0.99NT$ -1.60NT$ -1.84NT$ -1.12
Diluted EPSNT$ -1.36NT$ -0.99NT$ -1.60NT$ -1.84NT$ -1.12
Weighted Average Shares Outstanding214.01M214.01M191.32M183.96M183.89M
Weighted Average Shares Outstanding (Diluted)214.01M214.01M191.32M183.96M183.89M

Currency in TWD

CHO Pharma, Inc. Earnings and Revenue History

-400M-200M0200M-600000 %-400000 %-200000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin